Tiffany Tu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tiffany Tu has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Ochoa
Duke University
3 shared publications - Adaobi Uzoamaka Solarin
Department of Pediatrics, Lagos State University Teaching Hospital, Ikeja, Lagos, NIGERIA
1 shared publication - Adebowale Adeyemo
Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
1 shared publication - Aditi Sinha
Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
1 shared publication - Agnieszka Bierzynska
Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
1 shared publication - Ali G. Gharavi
Department of Medicine, Division of Nephrology, Columbia University College of Physicians and Surgeons, New York, New York, USA
1 shared publication
Latest Publications
- 12 May 2026
- Published by The R Foundation
metalcor: Meta-Analysis of Correlated Genetic Association Studies
The main function performs meta-analysis of genetic association study summary statistics that may be correlated due to cryptic relatedness or other confounders, generalizing inverse variance weighted methods. The function that estimates the correlation structure is also provided standalone. Another key innovation, the estimation of the correlation parameter from the median product of correlated standard normal variables, is provided, as well as a complete set of functions for their underlying distribution: density, cumulative, quantile, and random deviates. Described in Tu and Ochoa (2025) .
- 12 May 2026
- Published by The R Foundation
metalcor: Meta-Analysis of Correlated Genetic Association Studies
The main function performs meta-analysis of genetic association study summary statistics that may be correlated due to cryptic relatedness or other confounders, generalizing inverse variance weighted methods. The function that estimates the correlation structure is also provided standalone. Another key innovation, the estimation of the correlation parameter from the median product of correlated standard normal variables, is provided, as well as a complete set of functions for their underlying distribution: density, cumulative, quantile, and random deviates. Described in Tu and Ochoa (2025) .
- Open Access
Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome
Introduction: Nephrotic syndrome (NS), a common glomerular disease in children, is classified based on response to corticosteroid therapy as either steroid-sensitive nephrotic syndrome (SSNS), or steroid-resistant nephrotic syndrome (SRNS). However, there are currently no reliable predictors of therapy response at initial clinical presentation. Methods: We conducted genome-wide association studies, developed polygenic risk scores (PRS) for therapy response and analyzed classical HLA alleles in 1,997 (994 discovery and 1,003 replication/validation cohorts) previously unstudied children with NS and 3,558 ancestry-matched controls. Results: A significant association with HLA loci defined by variants in HLA-DQB1, HLA-DRB1 , and HLA-DQA1 were found for SSNS (but not SRNS), along with a second immune-related SSNS locus: CLEC16A . A PRS that discriminates between SSNS and SRNS was validated in two independent cohorts. The HLA haplotype HLA-DRB1*07:01∼DQA1*02:01∼DQB1*02:02 was associated with ∼4 times the risk of developing SSNS. A model incorporating HLA haplotype, PRS score, and age at onset of the disease was the best predictor of steroid responsiveness with an AUC of 0.68-0.70 and an overall classification accuracy of SSNS versus SRNS of 67-71%. Conclusions: Our findings confirm that SSNS (unlike SRNS) is an immune-mediated HLA-associated disorder. The PRS for therapy response and HLA haplotype can serve as biomarkers and provide a foundation for more accurate diagnoses and tailored and individualized treatment. Translational statement: To identify biomarkers of pattern of steroid responsiveness in childhood-onset nephrotic syndrome, we carried out a case-control study that included over 4,000 samples, including 994 patients with NS in the discovery phase and an additional 1,003 cases from two independent replication cohorts. We identified significant risk of steroid-sensitive NS (SSNS) at HLA class II genes and CLEC16A (a gene important in the regulation of T and B lymphocytes). The HLA haplotype DRB1*07:01∼DQA1*02:01∼DQB1*02:02 was associated with four-fold increased odds of SSNS. A model incorporating HLA haplotype, polygenic risk score, and age at onset of the disease was the best predictor of steroid responsiveness providing useful delineation of steroid sensitivity from steroid resistance. In conclusion, age at onset of disease, HLA class II variants and polygenic risk scores are useful biomarkers of corticosteroid response in childhood NS and may serve as useful clinical decision support tools to guide treatment. Abstract Figure: Graphical Abstract
Open AccessPolygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome
Introduction: Nephrotic syndrome (NS), a common glomerular disease in children, is classified based on response to corticosteroid therapy as either steroid-sensitive nephrotic syndrome (SSNS), or steroid-resistant nephrotic syndrome (SRNS). However, there are currently no reliable predictors of therapy response at initial clinical presentation. Methods: We conducted genome-wide association studies, developed polygenic risk scores (PRS) for therapy response and analyzed classical HLA alleles in 1,997 (994 discovery and 1,003 replication/validation cohorts) previously unstudied children with NS and 3,558 ancestry-matched controls. Results: A significant association with HLA loci defined by variants in HLA-DQB1, HLA-DRB1 , and HLA-DQA1 were found for SSNS (but not SRNS), along with a second immune-related SSNS locus: CLEC16A . A PRS that discriminates between SSNS and SRNS was validated in two independent cohorts. The HLA haplotype HLA-DRB1*07:01∼DQA1*02:01∼DQB1*02:02 was associated with ∼4 times the risk of developing SSNS. A model incorporating HLA haplotype, PRS score, and age at onset of the disease was the best predictor of steroid responsiveness with an AUC of 0.68-0.70 and an overall classification accuracy of SSNS versus SRNS of 67-71%. Conclusions: Our findings confirm that SSNS (unlike SRNS) is an immune-mediated HLA-associated disorder. The PRS for therapy response and HLA haplotype can serve as biomarkers and provide a foundation for more accurate diagnoses and tailored and individualized treatment. Translational statement: To identify biomarkers of pattern of steroid responsiveness in childhood-onset nephrotic syndrome, we carried out a case-control study that included over 4,000 samples, including 994 patients with NS in the discovery phase and an additional 1,003 cases from two independent replication cohorts. We identified significant risk of steroid-sensitive NS (SSNS) at HLA class II genes and CLEC16A (a gene important in the regulation of T and B lymphocytes). The HLA haplotype DRB1*07:01∼DQA1*02:01∼DQB1*02:02 was associated with four-fold increased odds of SSNS. A model incorporating HLA haplotype, polygenic risk score, and age at onset of the disease was the best predictor of steroid responsiveness providing useful delineation of steroid sensitivity from steroid resistance. In conclusion, age at onset of disease, HLA class II variants and polygenic risk scores are useful biomarkers of corticosteroid response in childhood NS and may serve as useful clinical decision support tools to guide treatment. Abstract Figure: Graphical Abstract
- Open Access
- 4 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Profiling Biological Effects of Microbiome Metabolites via Machine Learning
Human microbiome-derived metabolites are key mediators of host physiology. However, their biological effects remain largely uncharacterized due to limitations of current low-throughput and untargeted experimental approaches that are time-intensive and costly. This has hindered the systematic biological characterization of microbiome metabolites. To address this gap and accelerate the identification of biological effects of microbiome metabolites, we developed a machine learning platform trained on publicly available drug development data to rapidly predict a wide array of chemical and biological properties of microbiome metabolites. Prospective experimental validation confirmed the predictive accuracy of our models and uncovered previously unknown effects of several metabolites. For example, we identified previously unknown Interleukin-8 secretion stimulation by the metabolites spermine and spermidine, which have been regarded anti-inflammatory thus far. Our findings demonstrate the power of machine learning to accelerate the functional annotations of microbiome-derived metabolites, paving the way for new biomarker discovery and therapeutic development.
- 4 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessProfiling Biological Effects of Microbiome Metabolites via Machine Learning
Human microbiome-derived metabolites are key mediators of host physiology. However, their biological effects remain largely uncharacterized due to limitations of current low-throughput and untargeted experimental approaches that are time-intensive and costly. This has hindered the systematic biological characterization of microbiome metabolites. To address this gap and accelerate the identification of biological effects of microbiome metabolites, we developed a machine learning platform trained on publicly available drug development data to rapidly predict a wide array of chemical and biological properties of microbiome metabolites. Prospective experimental validation confirmed the predictive accuracy of our models and uncovered previously unknown effects of several metabolites. For example, we identified previously unknown Interleukin-8 secretion stimulation by the metabolites spermine and spermidine, which have been regarded anti-inflammatory thus far. Our findings demonstrate the power of machine learning to accelerate the functional annotations of microbiome-derived metabolites, paving the way for new biomarker discovery and therapeutic development.
- Open Access
Genetic association meta-analysis is susceptible to confounding by between-study cryptic relatedness
Meta-analysis of Genome-Wide Association Studies (GWAS) has important advantages, but it assumes that studies are independent, which does not hold when there is relatedness between studies. As a motivating example, recent work suggested applying sex-stratified meta-analysis to correct for participation bias, without considering that men and women from the same population will be highly related. Our theory demonstrates how cryptic relatedness results in correlated test statistics between studies, inflating meta-analysis. We characterize the effects of different between-study relatedness scenarios, particularly population structure and recent family relatedness, on meta-analysis type I error control and power. We simulated data with (1) no family relatedness between subpopulations, (2) family relatedness within subpopulations, (3) family relatedness across subpopulations, and (4) single population with family relatedness. We run joint and meta-analyses on simulations using both binary and quantitative traits. In scenarios with family relatedness, sex-stratified meta-analysis exhibits severe inflation and lower AUC compared to joint and subpopulation meta-analyses. Remarkably, genomic control succeeds in correcting inflation in these cases, but does not alter calibrated power. Analysis of real datasets confirms severe inflation for sex-stratified meta-analysis in family studies, but a negligible effect for population studies with up to 10,000 individuals. Our theoretical framework demonstrates that the inflation factor increases as the sample size increases. We recommend against meta-analyzing studies that share the same populations, which increases the risk of inflation due to cryptic relatedness between studies.
Open AccessGenetic association meta-analysis is susceptible to confounding by between-study cryptic relatedness
Meta-analysis of Genome-Wide Association Studies (GWAS) has important advantages, but it assumes that studies are independent, which does not hold when there is relatedness between studies. As a motivating example, recent work suggested applying sex-stratified meta-analysis to correct for participation bias, without considering that men and women from the same population will be highly related. Our theory demonstrates how cryptic relatedness results in correlated test statistics between studies, inflating meta-analysis. We characterize the effects of different between-study relatedness scenarios, particularly population structure and recent family relatedness, on meta-analysis type I error control and power. We simulated data with (1) no family relatedness between subpopulations, (2) family relatedness within subpopulations, (3) family relatedness across subpopulations, and (4) single population with family relatedness. We run joint and meta-analyses on simulations using both binary and quantitative traits. In scenarios with family relatedness, sex-stratified meta-analysis exhibits severe inflation and lower AUC compared to joint and subpopulation meta-analyses. Remarkably, genomic control succeeds in correcting inflation in these cases, but does not alter calibrated power. Analysis of real datasets confirms severe inflation for sex-stratified meta-analysis in family studies, but a negligible effect for population studies with up to 10,000 individuals. Our theoretical framework demonstrates that the inflation factor increases as the sample size increases. We recommend against meta-analyzing studies that share the same populations, which increases the risk of inflation due to cryptic relatedness between studies.